Treatment of pediatric hypertension

被引:17
作者
Temple, ME
Nahata, MC
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[3] Childrens Hosp, Columbus, OH 43205 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 02期
关键词
D O I
10.1592/phco.20.3.140.34782
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We conducted a MEDLINE search from January 1966-March 1999 to obtain information on clinical trials of treatment of pediatric hypertension. An article was selected for review if it described a randomized or nonrandomized study; randomized studies were given priority. Case reports were considered when studies were unavailable. Review articles were useful in identifying references. According to data we collected, hypertension is present in 1-3% of the pediatric population Nonpharmacologic treatment may be effective initially in those with mild to moderate disease or as an adjunct to drug therapy. Drugs for treatment of chronic hypertension include calcium channel blockers, angiotensin-converting enzyme inhibitors, diuretics, and beta-blockers. Patient and drug characteristics determine therapy. Intravenous labetalol, nicardipine, and nitroprusside are effective for treating hypertensive emergencies.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 69 条
[1]   MANAGEMENT OF HYPERTENSIVE URGENCIES AND EMERGENCIES [J].
ABDELWAHAB, W ;
FRISHMAN, W ;
LANDAU, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (08) :747-762
[2]  
ALPERT BS, 1993, PEDIATR CLIN N AM, V40, P13
[3]  
BOERTH RC, 1976, PEDIATR RES, V10, P328
[4]   LONG-TERM THERAPY BY CAPTOPRIL IN CHILDREN WITH RENAL-HYPERTENSION [J].
BOUISSOU, F ;
MEGUIRA, B ;
ROSTIN, M ;
FONTAINE, C ;
CHARLET, JP ;
BARTHE, P .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1986, 8 (4-5) :841-845
[5]   INTRAVENOUSLY ADMINISTERED LABETALOL FOR TREATMENT OF HYPERTENSION IN CHILDREN [J].
BUNCHMAN, TE ;
LYNCH, RE ;
WOOD, EG .
JOURNAL OF PEDIATRICS, 1992, 120 (01) :140-144
[6]   LONG-TERM TREATMENT WITH CAPTOPRIL IN PEDIATRIC-PATIENTS WITH SEVERE HYPERTENSION AND CHRONIC-RENAL-FAILURE [J].
CALLIS, L ;
VILA, A ;
CATALA, J ;
GRAS, X .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1986, 8 (4-5) :847-851
[7]   MANAGEMENT OF HYPERTENSIVE EMERGENCIES [J].
DEAL, JE ;
BARRATT, TM ;
DILLON, MJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (09) :1089-1092
[8]   NIFEDIPINE IN HYPERTENSIVE EMERGENCIES OF CHILDREN [J].
DILMEN, U ;
CAGLAR, MK ;
SENSES, DA ;
KINIK, E .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (12) :1162-1165
[9]   LACK OF EFFECT OF THE CALCIUM-ANTAGONIST ISRADIPINE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS [J].
ENDRESEN, L ;
BERGAN, S ;
HOLDAAS, H ;
PRAN, T ;
SINDINGLARSEN, B ;
BERG, KJ .
THERAPEUTIC DRUG MONITORING, 1991, 13 (06) :490-495
[10]   SUBLINGUAL NIFEDIPINE IN ACUTE SEVERE HYPERTENSION [J].
EVANS, JHC ;
SHAW, NJ ;
BROCKLEBANK, JT .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (08) :975-977